Home/Pipeline/SPRINT PNS for Chronic Low Back Pain

SPRINT PNS for Chronic Low Back Pain

Chronic Low Back Pain

ApprovedActive

Key Facts

Indication
Chronic Low Back Pain
Phase
Approved
Status
Active
Company

About SPR Therapeutics

SPR Therapeutics is a commercial-stage medical device innovator addressing the critical need for non-opioid chronic pain therapies through its proprietary peripheral nerve stimulation platform. The company's SPRINT® PNS System differentiates itself with a minimally invasive, temporary lead placement and a 60-day treatment regimen, aiming to provide lasting pain relief without permanent implants. Having secured FDA clearances for multiple pain indications, SPR is executing a commercial rollout in the U.S. while continuing to expand its clinical evidence and explore new applications. The company operates in a high-growth market driven by the opioid crisis and demand for effective, non-addictive pain management solutions.

View full company profile

Therapeutic Areas

Other Chronic Low Back Pain Drugs

DrugCompanyPhase
VER-01 for Chronic Low Back Pain (CLBP)VertanicalPhase 3